Injection site reaction: Difference between revisions
Jump to navigation
Jump to search
Adeel Jamil (talk | contribs) |
|||
| (6 intermediate revisions by 3 users not shown) | |||
| Line 9: | Line 9: | ||
=====Injection Site Pain===== | =====Injection Site Pain===== | ||
* [[Certolizumab pegol]] | |||
* [[Florbetapir F-18]] | |||
* [[Ibuprofen lysine]] | |||
* [[Human rabies virus immune globulin]] | |||
* [[Pegademase]] | |||
* Hydroxyprogesterone caproate Injection | |||
=====Injection Site Swelling===== | |||
* Hydroxyprogesterone caproate Injection | |||
=====Injection Site Pruritus===== | |||
* Hydroxyprogesterone caproate Injection | |||
==See Also== | ==See Also== | ||
Latest revision as of 01:23, 28 April 2015
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Injection site reactions are allergic reactions that result in cutaneous necrosis that may occur at sites of medication injection, typically presenting in one of two forms: (1) those associated with intravenous infusion or, (2) those related to intramuscular injection.[1]:123-4 Intramuscular injections may produce a syndrome called livedo dermatitis.
Causes
Injection Site Pain
- Certolizumab pegol
- Florbetapir F-18
- Ibuprofen lysine
- Human rabies virus immune globulin
- Pegademase
- Hydroxyprogesterone caproate Injection
Injection Site Swelling
- Hydroxyprogesterone caproate Injection
Injection Site Pruritus
- Hydroxyprogesterone caproate Injection
See Also
References
- ↑ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.